Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization

Microcirculation

Volumn 10, Issue 3-4, 2003, Pages 259-264

  Charo, Israel F ^a,b,c   Peters, Wendy ^a,b  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; CCR2; Chemokines; Interferon gamma; MCP 1

Indexed keywords

CD36 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CX3C CHEMOKINE; FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; CHEMOKINE RECEPTOR; MONOCYTE CHEMOATTRACTANT PROTEIN 1 RECEPTOR;

ANTIGEN PRESENTING CELL; ATHEROSCLEROSIS; CELL INFILTRATION; CELL POLARITY; CELL TRANSPORT; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; ENCEPHALITIS; GLOMERULONEPHRITIS; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LISTERIOSIS; LUNG MYCOSIS; LUNG TUBERCULOSIS; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKIN LEISHMANIASIS; T LYMPHOCYTE; ANIMAL; ARTERIOSCLEROSIS; INFECTION; METABOLISM; PHYSIOLOGY;

ANIMALS; ARTERIOSCLEROSIS; CELL POLARITY; HUMANS; INFECTION; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 0242273333     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7800191     Document Type: Review

References (43)

1. Aiello RJ, Bourassa P-AK, Lindsey S, Weng W, Natoli E, Rollins BJ, Milos PM. (1999). Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 19:1518-1525.
2. 3C motif. Nature 385:640-644.
3. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. (1998). A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 101:353-363.
4. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897.
5. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. (1990). Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87:5134-5138.
6. Dawson TC, Kuziel WA, Osahar TA, Maeda N. (1999). Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143:205-211.
7. Egashira K, Koyanagi M, Kitamoto S, Ni W, Kataoka C, Morishita R, Kaneda Y, Akiyama C, Nishida K-I, Sueishi K, Takeshita A. (2000). Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis, FASEB J 14:1974-1978.
8. Faggiotto A, Ross R, Harker L. (1984). Studies of hypercholesterolemia in the nonhuman primate: I. Changes that lead to fatty streak formation. Arteriosclerosis 4:323-340.
9. 3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion and activation under physiologic flow. J Exp Med 188:1413-1419.
10. Gerrity RG, Naito HK. (1980). Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. Artery 8:208-214.
11. Gerszten RE, Garcia-Zepeda EA, Lim Y-C, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rosenzweig A. (1999). MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718-723.
12. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF. (1999). MCP-1 deficiency reduces susceptibilily to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103:773-778.
13. Greaves DR, Häkkinen T, Lucas AD, Liddiard K, Jones E, Quinn CM, Senaratne J, Green FR, Tyson K, Boyle J, Shanahan C, Weissberg PL, Gordon S, Ylä-Hertualla S. (2001). Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21:923-929.
14. Grewal IS, Rutledge BJ, Fiorillo JA, Gu L, Gladue RP, Flavell RA, Rollins BJ. (1997). Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J Immunol 159:401-408.
15. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. (1998). Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2:275-281.
16. H2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404:407-411.
17. Han KH, Chang MK, Boullier A, Green SR, Li A, Glass CK, Quehenberger O. (2000). Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor γ. J Clin Invest 106:793-802.
18. Han KH, Han KO, Green SR, Quehenberger O. (1999). Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia: differential effects of plasma lipoproteins on monocyte function. J Lipid Res 40:1053-1063.
19. Han KH, Tangirala RK, Green SR, Quehenberger O. (1998). Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes: a regulatory role for plasma LDL. Arterioscler Thromb Vasc Biol 18: 1983-1991.
20. 3CR1-expressing cells is independent of G-protein activation. J Biol Chem 274:10053-10058.
21. 3CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin. Invest 108:679-688.
22. Huffnagle GB, McNeil LK, McDonald RA, Murphy JW, Toews GB, Maeda N, Kuziel WA. (1999). Cutting edge: role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol 163:4642-4646.
23. Huo Y, Weber C. Forlow SB, Sperandio M, Thatte J, Mack M, Jung S, Littman DR, Ley K. (2001). The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest 108:1307-1314.
24. Karpus WJ, Kennedy KJ. (1997). MIP-1α and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol 62:681-687.
25. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA. (1997). Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158:4129-4136.
26. Kurihara T, Warr G, Loy J, Bravo R. (1997). Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186:1757-1762.
27. Li AC, Brown KK, Silvestre MJ. Willson TM, Palinski W, Glass CK. (2000). Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106:523-531.
28. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. (1998). Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601-608.
29. McDermott DH, Halcox JPJ, Schenke WH, Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA, Murphy PM. (2001). Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89:401-407.
30. Moatti D, Faure S, Fumeron F, Amara MEW, Seknadji P, McDermott DH, Debré P, Aumont MC, Murphy PM, de Prost D, Combadière C. (2001). Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925-1928.
31. Nagy L. Tontonoz P, Alvarez JGA, Chen H, Evans RM. (1998). Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93:229-240.
32. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. (1991). Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88:1121-1127.
33. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A, von Andrian UH. (2001). Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 194:1361-1373.
34. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo J-A, Vath J, Gosselin M, Ma J, Dussault B, Woolf E, Alperin G, Culpepper J, Gutierrez-Ramos JC, Gearing D. (1997). Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611-617.
35. Peters W, Dupuis M, Charo IF. (2000). A mechanism for the impaired IFN-γ production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses. J Immunol 165:7072-7077.
36. Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, Ernst JD. (2001). Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 98:7958-7963.
37. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, Ahuja SS. (2000). CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells: Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 192:205-218.
38. Steinberg D. (1997). Lewis A. Conner memorial lecture: oxidative modification of LDL and atherogenesis. Circulation 95:1062-1071.
39. Szalai C, Duba J, Prohászka Z, Kalina Á, Szabó T, Nagy B, Horváth L, Császár A. (2001). Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD): coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158:233-239.
40. Tontonoz P, Nagy L, Alvarez JGA, Thomazy VA, Evans RM. (1998). PPARγ promotes monocyte/ macrophage differentiation and uptake of oxidized LDL. Cell 93:241-252.
41. Traynor TR, Herring AC, Dorf ME, Kuziel WA, Toews GB, Huffnagle GB. (2002). Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J Immunol 168:4659-4666.
42. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB. (2000). CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol 164:2021-2027.
43. Yu X, Dluz S, Graves DT, Zhang L, Antoniades HN, Hollander W, Prusty S, Valente AJ, Schwartz CJ, Sonenshein GE. (1992). Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 89:6953-6957.